Loading...
SPH | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 49 | |
SMR RATING 1..100 | 49 | |
PRICE GROWTH RATING 1..100 | 49 | |
P/E GROWTH RATING 1..100 | 11 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CVY | SPH | |
---|---|---|
RSI ODDS (%) | 4 days ago83% | 4 days ago64% |
Stochastic ODDS (%) | 4 days ago80% | 4 days ago54% |
Momentum ODDS (%) | 4 days ago82% | 4 days ago48% |
MACD ODDS (%) | 4 days ago86% | 4 days ago64% |
TrendWeek ODDS (%) | 4 days ago83% | 4 days ago51% |
TrendMonth ODDS (%) | 4 days ago78% | 4 days ago40% |
Advances ODDS (%) | 4 days ago84% | 12 days ago49% |
Declines ODDS (%) | 6 days ago80% | 4 days ago42% |
BollingerBands ODDS (%) | 4 days ago89% | 4 days ago57% |
Aroon ODDS (%) | 4 days ago79% | N/A |
A.I.dvisor indicates that over the last year, CVY has been loosely correlated with BAC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CVY jumps, then BAC could also see price increases.
A.I.dvisor tells us that SPH and NFE have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPH and NFE's prices will move in lockstep.